Six Novel P Gene Mutations and Oculocutaneous Albinism Type 2 Frequency in Japanese Albino Patients  by Suzuki, Tamio et al.
MUTATION REPORT
Six Novel P Gene Mutations and Oculocutaneous Albinism
Type 2 Frequency in Japanese Albino Patients
Tamio Suzuki,Yoshinori Miyamura, Jun Matsunaga,n Hiroshi Shimizu,wYasuhiro Kawachi,z Naoko Ohyama,y
Osamu Ishikawa,yTomoyuki Ishikawa,z Hiroshi Terao,nn and Yasushi Tomita
Department of Dermatology, Nagoya University Graduate School of Medicine; nDepartment of Dermatology,Tohoku University Graduate School of
Medicine, Sendai; wDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo; zDepartment of Dermatology, Institute of
Clinical Medicine, University of Tsukuba; yDepartment of Dermatology, Gunma University School of Medicine, Maebasi; zDepartment of Dermatology,
Semboku Kumiai General Hospital, Ohmagari; and nnDepartment of Dermatology, National Kokura Hospital, Kita-Kyushu, Japan
Type 2 oculocutaneous albinism (OCA2) is an auto-
somal recessive disorder that results from mutations
in the P gene that codes one of the melanosomal
proteins, the function of which remains unknown. In
this paper, we report the frequency of OCA2, 8%,
among the Japanese albino population, six novel muta-
tions containing four missense substitutions (P198L,
P211L, R10W, M398I), and two splice site mutations
(IVS15þ1 G4A, IVS241 G4C). One of them,
R10W, was within the putative signal peptide at the
N-terminal of the P protein. This is the ¢rst report on
the frequency of OCA2 in the Japanese albino popula-
tion. Key words: Japanese albino/OCA2/melanin. J Invest
Dermatol 120:781 ^783, 2003
O
culocutaneous albinism type 2 (OCA2:
MIM#203200) is an autosomal recessive disorder
in which the biosynthesis of melanin pigment is
reduced in the skin, hair, and eyes (Spritz, 1993). It
had been reported that human OCA2 is homolo-
gous to the mouse pink-eyed dilution gene (p), which codes for an
integral membrane protein with 12 putative transmembrane do-
mains (Gardner et al, 1992; Rinchik et al, 1993). The function of
the P gene product has not been clari¢ed yet, although several
potential functions have been proposed, e.g., a membrane trans-
porter of a substrate (Rosemblat et al, 1998), a sorter of tyrosinase
to the melanosome (Puri et al, 2000), a stabilizer of a melanosomal
protein complex (Manga and Orlow, 2001), a regulator of mela-
nosomal pH (Brilliant, 2001), and a controller of the processing
of tyrosinase, arsenic sensitivity, and cellular glutathione metabo-
lism (Chen et al, 2002; Staleva et al, 2002; Toyofuku et al, 2002).
The phenotypes of OCA2 patients are typically somewhat less
severe than in patients with oculocutaneous albinism type 1
(OCA1), which results from mutations of the tyrosinase gene,
although the two disorders display considerable clinical overlap.
This emphasizes the importance of genetic analysis in the diagno-
sis of albinism.
OCA2 is the most common type of albinism, especially in
African Black OCA patients, and accounts for approximately
50% of OCA worldwide (Oetting and King, 1999). Fewer than
50% of Caucasians clinically diagnosed with tyrosinase-positive
OCA, however, actually have a mutation in the P gene (Spritz,
1994), and, in the Asian population, ¢rm data are not available
on the frequency of OCA2 because only several patients have
been reported (Lee et al, 1994; Spritz et al, 1997; Saitoh et al,
2000). Here we report the spectrum of P gene mutations in 40
Japanese albino patients who were unrelated and lacked mutations
in the tyrosinase gene. This is the ¢rst report on the mutational
pro¢le of OCA2 in the Japanese albino patients.
MATERIALS ANDMETHODS
Mutation detection and con¢rmation A total of 40 Japanese OCA
patients, who were unrelated and lacked mutations in the tyrosinase gene,
were included in the mutational analysis. Using a genomic DNA
puri¢cation kit (Qiagen Hiden, Germany), genomic DNA was isolated
from peripheral blood of the patients and 104 unrelated normally
pigmented Japanese volunteers. The human P gene spans 25 exons, 24 of
which are the coding plus adjacent noncoding sequences, which were
ampli¢ed from genomic DNA by polymerase chain reaction (PCR) using
the primers described previously (Lee et al, 1995). The ampli¢ed fragments
were then screened for mutations by simultaneous analyses of single-
stranded conformation polymorphisms (SSCPs) and heteroduplexes
(Spritz et al, 1992). PCR products showing aberrant patterns were
reampli¢ed and sequenced directly.
This study was approved by the Ethical Committee of Nagoya
University Graduate School of Medicine.
RESULTS
Clinical ¢ndings and identi¢cation of novel mutations PCR-
SSCP/heteroduplex screening and direct sequencing of the P gene
detected six novel mutations in six out of 40 Japanese OCA
patients who lacked mutations in the tyrosinase gene (Table I).
These included four missense substitutions (P198L, P211L, R10W,
M398I) and two splice site mutations (Table II).
Patient 5 was a 24-y-old male with hazel irides and light skin.
He had had red brown hair, lighter skin, and a mongolian spot at
birth.Visual acuity was 20/30. There was no consanguinity, and his
one sibling was una¡ected. He was found to be heterozygous for
two di¡erent mutations in exons 14 and 15. The abnormality in
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exon 14 was a missense substitution, A481T, which is a common
mutant allele of the P gene in Caucasians (Lee et al, 1994), and
especially in Japanese (Suzuki et al, 2003). The other abnormality
in exon 15 was a substitution of adenine for guanine at the ¢rst
base of the ¢fteenth intervening sequence (IVS15), abolishing the
universal guanine^thymine dinucleotide that constitutes the 50
splice junction, a sequence element required for normal RNA
splicing. The IVS15þ1 G4A is a novel mutation.
Patient 7 was a 5-mo-old blond-haired male with nystagmus.
He had light skin, gray irides, and no mongolian spot. His visual
acuity seemed weaker than normal, although it could not be
assayed precisely. His parents were unrelated and he had no
siblings. He was found to be heterozygous for a novel missense
substitution, P198L, and no other mutation was identi¢ed.
Patient 13 was a 1-y-old blond female with brown irides, light
skin, nystagmus, and no mongolian spot. Her parents were
unrelated. She was found to be a compound heterozygote for two
novel mutations in exon 6 and exon 25.The abnormality in exon 6
was a novel missense substitution, P211L.The other abnormality in
exon 25 was a substitution of cytosine for guanine at the last base
of the twenty-fourth intervening sequence (IVS24), abolishing the
universal adenine^guanine dinucleotide that constitutes the 30
splice junction, a sequence element required for normal RNA
splicing. The IVS241 G4C is a novel mutation.
Patient 21 was a 1-y-old blond female with brown irides, light
skin, no nystagmus, and no mongolian spot. Her parents were
unrelated and she had no siblings. Her visual acuity appeared
normal, although it could not be assayed precisely. She was found
to be a compound heterozygote for one novel mutation, R10W,
and A481T. The screening of the exon 2 PCR product ampli¢ed
from 104 unrelated normal Japanese subjects indicated that one of
these subjects was heterozygous for the R10Wmutant allele (Table
II).Thus, the R10Wsubstitution appears to be a relatively common
mutant allele of the P gene, most probably associated with a
reduction of the P polypeptide function.
Patient 33 was a 71-y-old female with clinically severe OCA2.
She had blue irides, virtually white skin with no apparent
tanning ability, white hair, and nystagmus. She had squamous cell
carcinoma on her left hand and basal cell carcinoma on her face.
Her parents were unrelated and she had one a¡ected brother and
10 una¡ected siblings. She was found to be heterozygous for a
novel missense substitution, M394I; no other mutation was
identi¢ed.
Patient 35 was a 2-mo-old blond-haired male with no
nystagmus. He had brown irides, light skin, and no mongolian
spot. His visual acuity appeared normal, although it could not be
assayed. His parents were unrelated and his one sibling was
una¡ected. He was found to be heterozygous for two di¡erent
mutations, M394I, which was a novel mutation, and A481T.
Identi¢cation of polymorphisms SSCP revealed several
polymorphisms in the exonic or the nearby intronic sequences
in the P gene, and the frequencies were determined for 40 OCA
patients and 104 unrelated normal Japanese subjects (Table III).
Two of the exonic polymorphisms led to amino acid changes
(T387M, H615R), whereas the remaining ones were silent
(Table III).
DISCUSSION
We previously reported 35 patients with OCA1out of 75 Japanese
albino patients (Tomita et al, 2000). In this study, we performed
a mutational analysis on the remaining 40 albino patients with
regard to the P gene, and identi¢ed six di¡erent novel mutations
of the P gene in analyses of six unrelated patients with various
forms of OCA2. In two of these patients (7 and 33) we found
only one mutation, and it seems likely that the other allele
contains occult mutations either not detected by the SSCP/
heteroduplex screening procedure or occurring in gene regions
not sampled in the PCR products. The frequency of OCA2 in
the Japanese albino population was 8%, indicating that the P
gene was one of the major loci but was not as common as
OCA1 in Japanese, although OCA2 is the most common type of
albinism in African Blacks (Oetting and King, 1999) and repre-
sents 22% of the German albino population (Passmore et al,
1999). Thirty-four patients still remained as unclassi¢ed OCA,
supporting the idea that a third locus might be a major contribu-
tor to OCA (Spritz, 1994).
We examined the frequency of six mutant alleles identi¢ed
during this study in the P gene of 104 unrelated normal-pigmen-
ted Japanese subjects (208 alleles) (Table III), and only one allele
of the R10Wwas detected, indicating this mutant allele might be
one of the common ones in the Japanese population together
with the A481Tmutant allele (Suzuki et al, 2003).We statistically
judged that these novel mutations containing R10W were not
polymorphic but rather pathologic ones causing OCA2.
A previous study reported that most missense substitutions oc-
curred within the loops between the transmembrane domains
(Spritz, 1994). Of the four missense substitutions that we detected,
two were within these loops, and one, R10W, occurred in the
N-terminal cytoplasmic domain. R10 is thought to be within a
signal peptide that is an essential domain at the mRNA transla-
tion event on the surface of the rough endoplasmic reticulum.
The R10W substitution might prevent a correct P protein trans-
location from the cytosol into the endoplasmic reticulum,
because the transport is triggered by a signal peptide normally
Table I. Mutations of the P gene in six Japanese patients with OCA2
Patient Mutations detected Clinical phenotype Consanguinity
5 A481T (GCC4ACC)a/IVS15þ1 G4Ab Mild OCA2 ^
7 P198L (CCG4CTG)b/c Typical OCA2 ^
13 P211L (CCG4CTG)b/IVS241 G4Cb Typical OCA2 ^
21 R10W (CGG4TGG)b/A481T(GCC4ACC) Mild OCA2 ^
33 M394I (ATG4ATA)b/c Severe OCA2 ^
35 M394I (ATG4ATA)b/A481T(GCC4ACC)a Mild OCA2 ^
aThis mutation has already been reported.
bThese mutations are novel.
cSecond mutation was not identi¢ed.
Table II. Putative P gene mutations identi¢ed in this study
Pathogenic
variant
Position in the
P peptide
Number identi¢ed
in normal Japanese
(n¼ 208)
R10W N terminal cytoplasmic domain 1
P198L 1st luminal loop 0
P211L 1st luminal loop 0
M394 I 4th transmembrane domain 0
IVS15þ1 G4A Splice mutation 0
IVS24-1 G4C Splice mutation 0
n, number of allele.
782 SUZUKI ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
locating at the N terminus of polypeptides (Blobel and
Dobberstein, 1975). A functional assay using p-mutant melano-
cytes (Sviderskaya et al, 1997) might be warranted to con¢rm the
in£uence of the R10W substitution on melanogenesis. This is the
¢rst report that a missense mutation was identi¢ed within a pu-
tative signal peptide in the P gene.
The clinical phenotypes of six OCA2 patients identi¢ed in this
study showed a wide variety ^ three mild, two typical, and one
severe OCA2. All of three patients with the mild phenotype had
the A481T mutant allele, which is very common in the Japanese
population (12% of alleles from normal subjects) (Suzuki et al,
2003). These ¢ndings are totally consistent with the fact that the
A481T allele had approximately 70% functional activity in mela-
nogenesis compared with that of the wild-type human P cDNA
(Sviderskaya et al, 1997), suggesting that the other alleles contain-
ing IVS15þ1 G4A in patient 5, R10W in patient 21, and M391I
in patient 35 might have no or very low functional activity in
melanogenesis. This idea was supported by the fact that patient
33 showed a severe OCA2 phenotype and had the M391I allele,
although another mutation was not identi¢ed.
In conclusion, this study demonstrates that six novel mutations
in the P gene were found in six Japanese OCA patients, indicating
that OCA2 is one of the major types but less than OCA1 in
the Japanese population, and their clinical phenotypes varied
depending on their mutant genotypes. Accumulation of the
data on the relationships of phenotypes and genotypes of the P
gene is expected to give a new insight to the investigation on
melanogenesis.
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